Brain natriuretic peptide levels during cardiac reperfusion: Comparison between percutaneous coronary angioplasty and aorto-coronaric bypass

Clinica Chimica Acta

Volumn 342, Issue 1-2, 2004, Pages 87-92

  Palazzuoli, Alberto ^a   Carrera, Arcangelo ^a   Calabria, Paolo ^a   Pastore, Monica ^a   Quatrini, Ilaria ^a   Vecchiato, Lucia ^a   Campagna, Maria Stella ^a   Palazzuoli, Vincenzo ^a   Nuti, Ranuccio ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Brain natriuretic peptide; Cardiac reperfusion; Coronary angioplasty

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HEART SURGERY; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; REPERFUSION; TIME SERIES ANALYSIS;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL REPERFUSION INJURY; NATRIURETIC PEPTIDE, BRAIN; TIME FACTORS;

EID: 1542499944     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2003.11.021     Document Type: Article

References (20)

1. Stein B.C., Levine R.I. Natriuretic peptides: physiology, therapeutic potential, and risk stratification in ischaemic heart disease. Am. Heart J. 135:1998;914-923.
2. Crilley J.G., Farrer M. Left ventricular remodelling and brain natriuretic peptide after first myocardial infarction. Heart. 86:2001;638-642.
3. Cheng V., Kazanagra R., Garcia A., Lenert L., Krishnaswamy P., Gardetto N.et al. FACC A rapid beside test for B-type peptide predicts treatment outcomes in patients admitted for decompensed heart failure: a pilot study. J. Am. Coll. Cardiol. 37:2001;386-391.
4. Luchner A., Burnet J.C., Jougasaki M.et al. Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population. Hypertens. 18:2000;1121-1128.
5. Cheung B.M.Y., Kumana C.R. Natriuretic peptides relevance in cardiovascular disease. JAMA. 280:1998;1983-1984.
6. Arakawa N., Nakamura M., Aoki H., Kiramori K. Plasma brain natriuretic peptide concentration predict survival after acute MI. J. Am. Coll. Cardiol. 27:1996;1656-1661.
7. Usimaa P., Ruskoao H., Vuolteenaho O., Niemela M., Lumme J., Ikaheimo M.et al. Plasma vasoactive peptides after acute myocardial infarction in relation to left ventricular dysfunction. Int. J. Cardiol. 69:1999;5-14.
8. White M., Rouleau J.L., Hall C., Arnold M., Harel F., Sirosis P.et al. Changes in vasocostrictive hormones, natriuretic peptides, and left ventricular remodelling soon after anterior myocardial infarction. Am. Heart J. 142(6):2001 (Dec.);1056-1064.
9. Selvais P.L., Donckier J.E., Robert A., Laloux O., Van linden F., Ahn S.et al. Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation. Eur. J. Clin. Invest. 28:1998;636-642.
10. Rutherford J.D., Braunwald E. Coronary heart disease. Braunwald E. Heart Disease. 2:1997;1799-1869. 5th ed.
11. Arad M., Elazar E., Shotan A., Klein R., Rabinowitz B. Brain and atrial natriuretic peptides in patients with ischemic heart disease with and without heart failure. Cardiology. 87:1996;12-17.
12. De Lemos J.A., Morrow D.A., Bentley J.H., Omland T., Sabatine M.S., McCabe C.H.et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N. Engl. J. Med. 345:2001;1014-1021.
13. Kikuta K., Yasue H., Yoshimura M., Morita E., Sumida H., Kato H.et al. Increased plasma levels of B-type natriuretic peptide in patients with unstable angina. Am. Heart J. 132:1996;101-107.
14. Sabatine M.S., Morrow D.A., de Lemos J.A., Gibson C.M., Murphy S.A., Rifai N.et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes. Simultaneous assessment of troponin I, C-reactive protein, and B type natriuretic peptide. Circulation. 105:2002;1760-1763.
15. Talwar S., Squire I.B., Downie P.F., Davies J.E., Ng L.L. Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina. Heart. 84:2000;421-424.
16. Chello M., Mastroroberto P., Perticone F., Cirillo F., Bevacqua E., Olivito S.et al. Plasma levels of atrial brain natriuretic peptides as indicators of recovery of left ventricular systolic function after coronary artery bypass. Eur. J. Cardiothorac. Surg. 20:2001;140-146.
17. Avidan M.S., Meehan N., Ponte J., Gamel A.E., Sheerwood R. Changes in brain natriuretic peptide concentrations following open cardiac surgery with cardioplegic cardiac arrest. Clin. Chimica. Acta. 303:2001;127-132.
18. Mair P., Mair J., Bleier J., Hormann C., Balogh D., Puschendorf B. Augmented release of brain natriuretic peptide durin reperfusion of the human heart after cardioplegic cardiac arrest. Clin. Chim. Acta. 261:1997;57-68.
19. Maisel A.S., Krishnaswamy P., Nowak R.M., McCord J., Hollander J.E., Duc P.et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N. Engl. J. Med. 347:2002;161-167.
20. De Lemos J.A., Morrow D.A. Brain natriuretic peptide measurement in acute coronary syndromes: ready for clinical application? Circulation. 106:2002;2868-2870.